ESR1 and breast cancer: Interestingly, the information about molecular BC subtypes was available for the METABRIC and SCAN-B cohorts and clearly illustrated that high expression of BIRC5/survivin complemented the survival probability curves within the ER-positive patients, which are mostly the luminal B molecular subtype, and ER-negative, which are mostly the basal-like subtype.